Alteration of humoral and cellular immunity in manganese chloride‐treated mice
作者:
B. Srisuchart,
M. J. Taylor,
R. P. Sharma,
期刊:
Journal of Toxicology and Environmental Health
(Taylor Available online 1987)
卷期:
Volume 22,
issue 1
页码: 91-99
ISSN:0098-4108
年代: 1987
DOI:10.1080/15287398709531053
出版商: Taylor & Francis Group
数据来源: Taylor
摘要:
Immunological effects of manganese chloride (MnCl2) were determined in male CD‐1 mice injected (ip) daily with MnCl2(0, 1, 3, or 10 mg/kg) for 4 wk. Liver and spleen weights increased in the 10‐mg/kg MnCl2treatment group. The weights of thymus, kidney, and adrenal glands were not affected by MnCl2treatment. No significant differences in peripheral erythrocyte or leukocyte counts were observed; however, packed cell volumes decreased in the medium‐ and high‐dose groups. Manganese treatment significantly increased the uptake of [3H]thymidine (3H‐TdR) by cultured splenic cells. The lymphoproliferative responses to phytohemagglutinin (PHA) and concanavalin A (Con A) increased at all levels of MnCl2exposure. No differences in the responses to lipopolysaccharide (LPS) were observed. Mixed lymphocyte responses increased significantly with exposure to 10 mg MnCl2/kg. Another immunological alteration induced by MnCl2was a dose‐dependent immunosuppressive effect on the development of antibody‐forming cells. The production of anti‐sheep red blood cell antibody (α‐SRBC) nearly ceased following exposure to 10 mg MnCl2/kg. This effect was apparently reversible, as the number of plaque‐forming cells in the 10‐mg/kg treatment group increased after MnCl2treatment had been halted for 2 wk. The a‐SRBC titer also decreased significantly in the 10‐mg/kg treatment group, corresponding to the reduction of antibody‐producing cells. MnCl2treatment was immunomodulatory in male CD‐1 mice,asindicated by the increase in mitogen and mixed lymphocyte responses and decrease in antibody production.
点击下载:
PDF (504KB)
返 回